First Time Loading...

Crinetics Pharmaceuticals Inc
NASDAQ:CRNX

Watchlist Manager
Crinetics Pharmaceuticals Inc Logo
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Watchlist
Price: 46.86 USD -1.29% Market Closed
Updated: May 29, 2024

Crinetics Pharmaceuticals Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Crinetics Pharmaceuticals Inc
Research & Development Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
Research & Development
-$183.4m
CAGR 3-Years
-45%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Research & Development
-$7.3B
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Research & Development
-$6B
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Research & Development
-$5B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Research & Development
-$3.5B
CAGR 3-Years
-24%
CAGR 5-Years
-19%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Research & Development
-$4.6B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-17%

See Also

What is Crinetics Pharmaceuticals Inc's Research & Development?
Research & Development
-183.4m USD

Based on the financial report for Mar 31, 2024, Crinetics Pharmaceuticals Inc's Research & Development amounts to -183.4m USD.

What is Crinetics Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-47%

Over the last year, the Research & Development growth was -31%. The average annual Research & Development growth rates for Crinetics Pharmaceuticals Inc have been -45% over the past three years , -47% over the past five years .